Cargando…
Spotlight on mavrilimumab for the treatment of rheumatoid arthritis: evidence to date
The introduction of biological therapies into clinical practice has dramatically modified the natural history of chronic inflammatory diseases, such as rheumatoid arthritis (RA). RA is a systemic autoimmune disease that causes articular damage and has a great negative impact on patients’ quality of...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5245809/ https://www.ncbi.nlm.nih.gov/pubmed/28144129 http://dx.doi.org/10.2147/DDDT.S104233 |